WordNet

(medicine) an immunological response that refuses to accept substances or organisms that are recognized as foreign; "rejection of the transplanted liver"
the state of being rejected
the act of rejecting something; "his proposals were met with rejection"
the speech act of rejecting
occupy an intermediate or middle position or form a connecting link or stage between two others; "mediate between the old and the new"
acting through or dependent on an intervening agency; "the disease spread by mediate as well as direct contact"
being long-lasting and recurrent or characterized by long suffering; "chronic indigestion"; "a chronic shortage of funds"; "a chronic invalid"
of long duration; "chronic money problems" (同)continuing
habitual; "a chronic smoker" (同)inveterate
any of a large variety of proteins normally present in the body or produced in response to an antigen which it neutralizes, thus producing an immune response
acting or brought about through an intervening agency; "the mediated settlement brought satisfaction to both sides"

PrepTutorEJDIC

〈U〉〈C〉断ること,拒絶;却下 / 〈C〉廃棄物
〈紛争・相違点など〉‘を'調停する,仲裁する / 〈妥協・和解・同意など〉‘を'仲裁して成立させる / (両者の)調停をする《+『between』+『名』》 / 仲介者(媒介物)を通じての,間接の
(病気が)長期にわたる,慢性の / 《名詞の前にのみ用いて》常習の,癖になった
抗体,免疫体,抗毒素

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 腎同種移植片のC4d染色および抗体媒介性拒絶反応の治療 c4d staining in renal allografts and treatment of antibody mediated rejection
2. 慢性腎同種移植片腎症 chronic renal allograft nephropathy
3. 肺移植における抗体媒介性拒絶反応の評価および治療 evaluation and treatment of antibody mediated lung transplant rejection
4. 心肺移植 heart lung transplantation
5. 急性心臓同種移植拒絶反応：診断 acute cardiac allograft rejection diagnosis

HLA-G*01:04∼UTR3 Recipient Correlates With Lower Survival and Higher Frequency of Chronic Rejection After Lung Transplantation.

Di Cristofaro J1, Reynaud-Gaubert M2, Carlini F1, Roubertoux P3, Loundou A4, Basire A5, Frassati C5, Thomas P6, Gomez C2, Picard C1,5.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.Am J Transplant.2015 Sep;15(9):2413-20. doi: 10.1111/ajt.13305. Epub 2015 May 18.
Lung transplantation (LTx) is a valid therapeutic option for selected patients with end-stage lung disease. Soluble HLA-G (sHLA-G) has been associated with increased graft survival and decreased rejection episodes in solid organ transplantation. HLA-G haplotypes named UTRs, defined by SNPs from both
PMID 25989360

Therapeutic Plasma Exchange Using the Spectra Optia Cell Separator Compared With the COBE Spectra.

Kim do K1, Kim S1, Jeong SH1, Kim HO1, Kim HJ2.
Annals of laboratory medicine.Ann Lab Med.2015 Sep;35(5):506-9. doi: 10.3343/alm.2015.35.5.506.
BACKGROUND: The Spectra Optia (SPO) is a novel continuous-flow centrifugal apheresis system based on the COBE Spectra (CSP) platform. There have been few attempts to validate the advantages of the SPO. We performed a retrospective study comparing the two cell separators for therapeutic plasma exchan
PMID 26206687

A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation.

Rascio F1, Pontrelli P2, Accetturo M2, Oranger A2, Gigante M2, Castellano G2, Gigante M3, Zito A2, Zaza G4, Lupo A4, Ranieri E3, Stallone G1, Gesualdo L2, Grandaliano G1.
The Journal of pathology.J Pathol.2015 Sep;237(1):72-84. doi: 10.1002/path.4553. Epub 2015 Jun 4.
Chronic antibody-mediated rejection (CAMR) represents the main cause of kidney graft loss. To uncover the molecular mechanisms underlying this condition, we characterized the molecular signature of peripheral blood mononuclear cells (PBMCs) and, separately, of CD4(+) T lymphocytes isolated from CAMR
PMID 25925804

甲斐耕太郎
日本アフェレシス学会雑誌 29(3), 242-246, 2010-10-31
… Apheresis therapies such as plasma exchange or Double-filtration plasmapheresis (DFPP) were performed in renal transplantation to remove preoperative anti-blood type antibody or anti-HLA antibody. … Here we show our preoperative desensitized protocol in ABO incompatible renal transplantation and the impact of pre- or postoperative titers of anti-blood type antibody against graft survival. …
NAID 110007880246